CorMedix Inc. to Report Fourth Quarter 2019 Financial Results and Provide a Corporate Update on March 16

    NEXT STORY
    Cerecor Announces Appointment of H. Jeffery Wilkins MD as Chief Development Officer
    PREV STORY
    $5.3 Billion UV Disinfection Equipment Market by Component, Power Rating, Application, End-User, and Region – Global Forecast to 2025
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Inovio Pharmaceuticals to Report Third Quarter 2018 Financial Results on November 8, 2018

    PLYMOUTH MEETING, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) ...

    author_avatar
    NASDAQ Market News

    Coherus BioSciences Submits 351(k) Biologics License Application to U.S. Food and Drug Administration for CHS-1701 (Pegfilgrastim Biosimilar Candidate)

    REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today ...

    author_avatar
    NASDAQ Market News

    Saniona AB: Saniona participates in formation of Scandion Oncology and spins out clinical program and related ion channel platform

    PRESS RELEASE May 3, 2017 Saniona, a leading biotech company in the field of ...

    author_avatar
    NASDAQ Market News